Sagimet Biosciences (SGMT) Gains from Sales and Divestitures (2024 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly Gains from Sales and Divestitures of $63508.0 in Q1 2026, down 77.44% quarter-over-quarter from $281462.0 in Q4 2025.
Sagimet Biosciences (SGMT) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Sagimet Biosciences' Gains from Sales and Divestitures history runs 3 years deep, the most recent figure standing at $63508.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures changed N/A year-over-year to $63508.0; the TTM figure through Mar 2026 stood at $63508.0 (changed N/A YoY), while the FY2025 annual figure was $281462.0, changed 0.0% from the prior year.
- Gains from Sales and Divestitures was $63508.0 for Q1 2026 at Sagimet Biosciences, down from $281462.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $281462.0 in Q3 2025 to a low of $63508.0 in Q1 2026.
- Historically, Gains from Sales and Divestitures has averaged $237869.6 across 3 years, with a median of $281458.0 in 2024.
- Biggest YoY gain for Gains from Sales and Divestitures was 0.0% in 2025; the steepest drop was 0.0% in 2025.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $281458.0 in 2024, then increased by 0.0% to $281462.0 in 2025, then tumbled by 77.44% to $63508.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $63508.0 (Q1 2026), $281462.0 (Q4 2025), and $281462.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,508.00 |
| Mar 31, 2026 | 63,508.00 |
| Dec 31, 2025 | 281,462.00 |
| Dec 31, 2025 | 281,462.00 |
| Sep 30, 2025 | 281,462.00 |
| Sep 30, 2025 | 281,462.00 |
| Dec 31, 2024 | 281,458.00 |
| Dec 31, 2024 | 281,458.00 |
| Sep 30, 2024 | 281,458.00 |
| Sep 30, 2024 | 281,458.00 |